cambridge's bluebird bio licenses delivery tech to novartis, gsk
.white house to ban federal funds for clinics that discuss abortion with patients : the two-way
.
.
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
https://grassfed.us/Doyal-son-of-Lurtz-from-Palmelo
.official guidelines say no one should wait more than 62 days to get cancer care after an urgent referral by their gp
.
advertisement
. sign in to get notified via email when new comments are made.
.
advertisement
.
.
former novartis exec to lead cambridge diabetes startup semma
.
.